Company intelligence / Profile preview

Housey Healthcare

Southfield, Michigan, United Statesaxulin.com ↗

Ownership: Private
Development stage: Other

Overview

Housey Healthcare develops and licenses advanced cell-based assay technologies enabling the discovery of drugs against previously "undruggable" targets. Its platform has been widely licensed by major pharmaceutical companies. The company also markets Axulin, a nutritional supplement targeting blood sugar regulation. No clinical-stage therapeutic assets are publicly disclosed; the main commercial activity appears to be technology licensing and nutraceutical sales[1][3][4].

Therapeutic areas: EndocrinologyOncologyNeurology
Modalities: Small moleculeNutritional supplement
Industry: Drug Discovery Services

Partnerships

Novartis Institutes for BioMedical ResearchBristol Myers SquibbF. Hoffmann-La RocheJanssen Pharmaceutical division of Johnson & Johnson

Beyond the preview

Go deeper on Housey Healthcare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Housey Healthcare.

Explore the full profile